SIMCor is a 3-year (2021-2023) Horizon 2020 research and innovation action developing a computational platform for in-silico development, validation and regulatory approval of cardiovascular implantable devices
Provide proof-of-validation for virtual cohorts and computer-based simulation of cardiovascular device implantation and performance
Develop standards and protocols for in-silico testing and validation of cardiovascular devices
Quantify the benefits of in-silico testing for healthcare, industry and society as a whole
Accelerate the integration of in-silico testing into the medical device regulatory approval process, the market and the clinics
Contribute to the European Open Science Cloud with data, virtual cohorts, simulation models, methodologies, standards and guidelines
Image by Mario Zogheb from Pixabay.
Das Postfuhramt (Berlin). Photo credits: Matthias Süßen, CC BY-SA 4.0, via Wikimedia Commons